The growing nee

The growing need for cancer immunotherapy, advancements in autoimmune research, and the critical role of IL-2 in CAR-T/NK therapies are propelling market expansion. Leading players like Novartis (Proleukin), Alkermes, NeoImmuneTech, Eli Lilly, and Nektar Therapeutics are at the forefront. Innovations such as engineered IL-2 variants and combination therapies are accelerating progress in this dynamic immunology sector.

For detailed insights:

https://www.delveinsight.com/infographics/interleukin-2-market-forecast?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr